Taysha Gene Therapies
TSHA
TSHA
105 hedge funds and large institutions have $354M invested in Taysha Gene Therapies in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 28 increasing their positions, 21 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
-3
Holders Change %
-2.78%
% of All Funds
1.53%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
35
Increased
28
Reduced
21
Closed
38
Calls
$208K
Puts
$99K
Net Calls
+$109K
Net Calls Change
+$118K
Top Buyers
| 1 |
BlackRock
New York
|
+$20.5M |
| 2 |
State Street
Boston,
Massachusetts
|
+$6.67M |
| 3 |
JPMorgan Chase & Co
New York
|
+$6.43M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$5.68M |
| 5 |
Morgan Stanley
New York
|
+$5.17M |
Top Sellers
| 1 |
EP
Eversept Partners
New York
|
-$6.67M |
| 2 |
Millennium Management
New York
|
-$6.26M |
| 3 |
CAC
Cowen and Company
New York
|
-$4.45M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.19M |
| 5 |
SC
Stempoint Capital
New York
|
-$3.12M |
